e-learning
resources
Virtual 2020
Pre-Congress Content
Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk factors for low forced vital capacity in the multinational BOLD study: An update
A. Amaral (London, United Kingdom), J. Patel (London, United Kingdom), A. Buist (Portland, OR, United States of America), P. Burney (London, United Kingdom), .. On Behalf Of The Bold Collaborative Research Group (., United Kingdom)
Source:
Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Session:
Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Session type:
E-poster session
Number:
1425
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Amaral (London, United Kingdom), J. Patel (London, United Kingdom), A. Buist (Portland, OR, United States of America), P. Burney (London, United Kingdom), .. On Behalf Of The Bold Collaborative Research Group (., United Kingdom). Risk factors for low forced vital capacity in the multinational BOLD study: An update. 1425
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Airway responsiveness predicts lung function decline differently in subjects with or without asthma: An international study
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
Evaluation of novel augmented reality based mobile application to record peak expiratory flow rates
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Late Breaking Abstract - Objective physical activity as a clinical trial outcome in patients with COPD: a view on the literature from a task force of experts in the field
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
Agreement between direct and estimated maximum ventilatory ventilation in health subjects: A multicentric study
Source: International Congress 2014 – Assessment and techniques of physiotherapy: from healthy subjects to critical patients
Year: 2014
Educational information events to enhance recruitment to clinical research trials
Source: International Congress 2015 – New developments in medical education, web and internet
Year: 2015
RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021
Predictors of accelerated decline in FEV1 in a prospective new-onset asthma cohort
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Understanding the analysis of the Canadian lung volume reduction surgery (CLVR) trial: future applications
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008
Progression of physical inactivity in COPD patients: the effect of time and climate conditions – a multicentre prospective cohort study
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
The short-term prognostic value of forced expiratory volume in 1 second divided by height cubed (FEV1.Ht
-3
) in a prospective cohort of people 80 years and older
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Pooled clinical trial analysis of the rate of decline in FEV1 according to perceived dyspnea and health status
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008
Late Breaking Abstract - Optimizing FEV1/FVC threshold to predict COPD hospitalization and mortality: NHLBI pooled cohorts study
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018
Risk factors for a low FVC in the BOLD project
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014
Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
The impact of COPD on health status: findings from the BOLD study
Source: Eur Respir J 2013; 42: 1472-1483
Year: 2013
Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality
Source: Eur Respir J 2010; 36: 1002-1006
Year: 2010
Late Breaking Abstract: Dyspnea prevalence varies by health, sex, and country: Results from the BOLD study
Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease
Year: 2010
Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept